Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SABS compared with ANTX: revenue, margins and what each company keeps, and the suppliers and customers both name
SABS
SAB Biotherapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
ANTX
AN2 Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
SABS
SAB Biotherapeutics, Inc.
vs
ANTX
AN2 Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
SABS
SAB Biotherapeutics, Inc.
Change
3.30
▲
+5.88%
Mkt cap
$300.3M
Revenue
$114,698
Q4 FY24
ANTX
AN2 Therapeutics, Inc.
Change
4.23
▲
+1.20%
Regular session
Nov 4 '26
Mkt cap
$157.7M
Revenue
—
vs
Compare
Regular session
Nov 4 '26
SABS
SAB Biotherapeutics, Inc.
vs
ANTX
AN2 Therapeutics, Inc.
3.30
▲
+5.88%
Price
4.23
▲
+1.20%
$300.3M
Mkt cap
$157.7M
Q4 FY24
$114,698
Revenue
—
Change
Change
SABS
3.30
▲
+5.88%
vs
ANTX
4.23
▲
+1.20%
Regular session
Nov 4 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
SABS: latest quarter is a loss; flow not drawable. ANTX: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only SABS
5
EBS
Emergent BioSolutions Canada
supplier
—
Avance Clinical PTY, Ltd ("Avance")
unlisted
supplier
—
Fortrea Holdings Inc. ("Fortrea")
unlisted
supplier
—
Sanford Applied Biosciences
unlisted
supplier
1 more · SABS chain
›
Shared
0
No disclosed counterparties: ANTX.
Only ANTX
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
SABS, solid
ANTX, dashed